Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vivli Nonprofit Hopes To Be One-Stop Shop For Clinical Trial Data

Executive Summary

GlaxoSmithKline, Pfizer, and Biogen are among those participating in new data-sharing and analytics platform; 2,500 trials currently available to researchers.

You may also be interested in...

Clinical Trial Data Sharing: IOM Envisions Open And Closed Doors

Institute of Medicine report calls for greater, faster availability of full clinical trial data sets, but with no authority and many loopholes, impact on status quo may be minimal.

Clinical Trial Data Disclosure: As EMA Pushes For Patient Level Info, What Control Will Firms Have?

European Medicines Agency plans to require publication of all raw clinical trial data as of January 2014. While industry fears this policy will result in release of confidential commercial information, GSK is making patient-level data available to certain researchers.

Turning COVID-19 Vaccine EUA Into A BLA Will Require Six Months Of Additional Data

US FDA’s Peter Marks notes timeframe for sponsors to seek licensure at press call announcing emergency use authorization of J&J’s vaccine; Acting Commissioner Woodcock says effectiveness comparisons cannot be made between the three authorized vaccines since they have not been tested head-to-head.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts